Tuba Tulay Koca1, Cemile Buket Tugan2, Muhammet Seyithanoglu3, Burhan Fatih Kocyigit1. 1. Department of Physical Medicine and Rehabilitation, Sütçü İmam University, Kahramanmaras, Turkey. 2. Department of Neurology, Sütçü İmam University School of Medicine, Kahramanmaras, Turkey. 3. Department of Clinic Biochemistry, Sütçü İmam University School of Medicine, Kahramanmaras, Turkey.
Abstract
OBJECTIVE: Cardiovascular complications are still the primary reason for high mortality rates worldwide. The determination of risk factors is important to prevent stroke. The aim of the present study was to analyze the importance of serum lipid indexes and urinary sodium (Na)/potassium (K) excretion in patients with stroke together with sex differences. MATERIALS AND METHODS: A total of 50 (28 male and 22 female, mean age 65.9±14.6 years) patients with acute stroke were included in the study group, and 32 body mass index-matched healthy subjects were included in the control group. Lipid profiles [(cholesterol, triglyceride, very low-density lipoprotein, low-density lipoprotein, and high-density lipoprotein (HDL)], serum creatinine (Cre), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and Na, K, and Cre excretion in spot urine samples of the patients were recorded. RESULTS: Systolic blood pressure (p=0.021), ESR (p=0.044), and CRP (p=0.042) were significantly higher in all patients in the stroke group; urinary Tanaka (K) (p=0.033), Kawazaki (K) (p=0.028), urinary spot Cre (p=0.012), and Na excretion (p=0.036) levels were found to be significantly lower in only male patients with stroke. The mean plasma atherogenic indexes were 0.57±0.24 in the study (stroke) group and 0.54±0.22 in the control group (p=0.61). Other lipid indexes, such as Castelli's risk index (CRI)-I (p=0.29), CRI-II (p=0.24), atherogenic coefficient (p=0.29), and non-HDL cholesterol (p=0.69), were not statistically different from the controls. CONCLUSION: Urinary Na, K, and Cre excretion was significantly lower in male patients with stroke, and acute phase reactants were significantly higher in the entire stroke group than in controls. These parameters can be used as auxiliary biomarkers in the risk assessment of stroke.
OBJECTIVE: Cardiovascular complications are still the primary reason for high mortality rates worldwide. The determination of risk factors is important to prevent stroke. The aim of the present study was to analyze the importance of serum lipid indexes and urinary sodium (Na)/potassium (K) excretion in patients with stroke together with sex differences. MATERIALS AND METHODS: A total of 50 (28 male and 22 female, mean age 65.9±14.6 years) patients with acute stroke were included in the study group, and 32 body mass index-matched healthy subjects were included in the control group. Lipid profiles [(cholesterol, triglyceride, very low-density lipoprotein, low-density lipoprotein, and high-density lipoprotein (HDL)], serum creatinine (Cre), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and Na, K, and Cre excretion in spot urine samples of the patients were recorded. RESULTS: Systolic blood pressure (p=0.021), ESR (p=0.044), and CRP (p=0.042) were significantly higher in all patients in the stroke group; urinary Tanaka (K) (p=0.033), Kawazaki (K) (p=0.028), urinary spot Cre (p=0.012), and Na excretion (p=0.036) levels were found to be significantly lower in only male patients with stroke. The mean plasma atherogenic indexes were 0.57±0.24 in the study (stroke) group and 0.54±0.22 in the control group (p=0.61). Other lipid indexes, such as Castelli's risk index (CRI)-I (p=0.29), CRI-II (p=0.24), atherogenic coefficient (p=0.29), and non-HDL cholesterol (p=0.69), were not statistically different from the controls. CONCLUSION: Urinary Na, K, and Cre excretion was significantly lower in male patients with stroke, and acute phase reactants were significantly higher in the entire stroke group than in controls. These parameters can be used as auxiliary biomarkers in the risk assessment of stroke.
Authors: Martin J O'Donnell; Salim Yusuf; Andrew Mente; Peggy Gao; Johannes F Mann; Koon Teo; Matthew McQueen; Peter Sleight; Arya M Sharma; Antonio Dans; Jeffrey Probstfield; Roland E Schmieder Journal: JAMA Date: 2011-11-23 Impact factor: 56.272
Authors: Lyanne M Kieneker; Ron T Gansevoort; Rudolf A de Boer; Frank P Brouwers; Edith Jm Feskens; Johanna M Geleijnse; Gerjan Navis; Stephan Jl Bakker; Michel M Joosten Journal: Am J Clin Nutr Date: 2016-03-16 Impact factor: 7.045
Authors: Ross L Prentice; Ying Huang; Marian L Neuhouser; JoAnn E Manson; Yasmin Mossavar-Rahmani; Fridtjof Thomas; Lesley F Tinker; Matthew Allison; Karen C Johnson; Sylvia Wassertheil-Smoller; Arjun Seth; Jacques E Rossouw; James Shikany; Laura D Carbone; Lisa W Martin; Marcia L Stefanick; Bernhard Haring; Linda Van Horn Journal: Am J Epidemiol Date: 2017-11-01 Impact factor: 5.363